← 產業報告目錄
Autoinjector Market Size, Share & Trends Analysis Report By Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Therapeutic Indication, Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-28頁數 180報告編號 INSIGHTACE-348611c9da
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Autoinjector Market on a global scale was estimated at USD 1.1 Bn in 2024 and is set to attain USD 4.7 Bn by 2034, with a projected CAGR of 15.4% between 2025 and 2034.
Autoinjector covers pen-like devices that deliver a fixed dose of medication to a patient and are meant to be self-administered. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is driven by surging call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Autoinjectors Market Snapshot
Chapter 4. Global Autoinjectors Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter's Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. COVID 19 Impact Analysis 2021
Chapter 5. Market Segmentation 1: Type Estimates & Trend Analysis
5.1. Type & Market Share, 2024 & 2034
5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:
5.2.1. Disposable autoinjectors
5.2.2. Reusable autoinjectors
Chapter 6. Market Segmentation 2: Applications & Trend Analysis
6.1. Applications & Market Share, 2024 & 2034
6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following Applications:
6.2.1. Rheumatoid Arthritis
6.2.2. Anaphylaxis
6.2.3. Multiple Sclerosis
6.2.4. Others
Chapter 7. Market Segmentation 3: End-Users & Trend Analysis
7.1. End-Users & Market Share, 2024 & 2034
7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-Users:
7.2.1. Home care settings
7.2.2. Hospitals & Clinics
Chapter 8. Autoinjectors Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts Type, 2021-2034
8.1.2. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2021-2034
8.1.3. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2021-2034
8.1.4. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) Type, 2021-2034
8.2.2. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2021-2034
8.2.3. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2021-2034
8.2.4. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) Type, 2021-2034
8.3.2. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2021-2034
8.3.3. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2021-2034
8.3.4. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) Type, 2021-2034
8.4.2. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2021-2034
8.4.3. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2021-2034
8.4.4. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. MEA
8.5.1. MEA Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts Type, 2021-2034
8.5.2. MEA Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2021-2034
8.5.3. MEA Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2021-2034
8.5.4. MEA revenue Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
8.5.4.1. South Africa
8.5.4.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Amgen Inc.
9.2.2. Antares Pharma
9.2.3. Becton, Dickinson, And Company (BD)
9.2.4. ELI LILLY AND COMPANY
9.2.5. Johnson & Johnson
9.2.6. MYLAN N.V.
9.2.7. Novartis AG
9.2.8. SHL MEDICAL AG
9.2.9. TEVA Pharmaceutical Industries LTD.
9.2.10. YPSOMED AG
9.2.11. ATS Automation Tooling Systems Inc.
9.2.12. Owen Mumford Ltd.
9.2.13. SHL Group
9.2.14. Oval Medical Technologies Ltd.
9.2.15. E3D Elcam Drug Delivery Devices
9.2.16. kaleo, Inc.
9.2.17. Crossject
9.2.18. Gerresheimer AG
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們